Mylan Claims Celgene Is Blocking Cancer Drug Generics
Mylan Pharmaceuticals Inc. on Thursday filed an antitrust suit against Celgene Corp. in New Jersey federal court, accusing Celgene of maintaining monopolies over the markets for its blockbuster cancer drugs Thalomid...To view the full article, register now.
Already a subscriber? Click here to view full article